Impact of Estimated Plasma Volume Status on Mortality in Right Heart Failure Patients: A Retrospective Cohort Study in Indonesia

Background: Plasma volume (PV) expansion hallmarks the syndrome of heart failure (HF) but is difficult to be quantified noninvasively. Estimated plasma volume status (ePVS) has marked prognostic utility in the failing left heart, however its use in right heart failure (RHF) remains unknown. This stu...

Full description

Bibliographic Details
Main Authors: Hannah Soetjoadi, Dewi Friska, Bambang Budi Siswanto, Hary Sakti Muliawan
Format: Article
Language:English
Published: Ubiquity Press 2022-08-01
Series:Global Heart
Subjects:
Online Access:https://globalheartjournal.com/articles/1136
_version_ 1828143805183819776
author Hannah Soetjoadi
Dewi Friska
Bambang Budi Siswanto
Hary Sakti Muliawan
author_facet Hannah Soetjoadi
Dewi Friska
Bambang Budi Siswanto
Hary Sakti Muliawan
author_sort Hannah Soetjoadi
collection DOAJ
description Background: Plasma volume (PV) expansion hallmarks the syndrome of heart failure (HF) but is difficult to be quantified noninvasively. Estimated plasma volume status (ePVS) has marked prognostic utility in the failing left heart, however its use in right heart failure (RHF) remains unknown. This study aims to investigate the prognostic value of ePVS among isolated RHF patients. Methods: We retrospectively collected 208 patients admitted for RHF in our hospital from the electronic database from 2017 to 2019. ePVS was calculated using the Hakim formula. Patients were divided into low and high groups based on their PV value. Logistic regression was used to compare the odds of in-hospital mortality between these groups. Results: The overall in-hospital mortality was 12.5%, tripled from the low group to the high group (6.7% vs. 18.3%), within a median of 6 (3–19) days. High ePVS significantly predicted mortality in RHF, even after being adjusted for demographic, hemodynamic, chemistry, and medication variables (adjusted OR: 5.83, 95% CI: 1.62–20.95, 'p' < 0.01). Conclusion: ePVS is associated with in-hospital mortality among isolated RHF patients. Given not only the wide accessibility of hemogram but also the low cost and the rapid quantification of relative PV, this simple tool can potentially aid in optimizing RHF management, especially in rural area, although further evaluation is warranted.
first_indexed 2024-04-11T20:05:48Z
format Article
id doaj.art-5aef233ba6724a289c8cecbef9607f07
institution Directory Open Access Journal
issn 2211-8179
language English
last_indexed 2024-04-11T20:05:48Z
publishDate 2022-08-01
publisher Ubiquity Press
record_format Article
series Global Heart
spelling doaj.art-5aef233ba6724a289c8cecbef9607f072022-12-22T04:05:20ZengUbiquity PressGlobal Heart2211-81792022-08-0117110.5334/gh.1136967Impact of Estimated Plasma Volume Status on Mortality in Right Heart Failure Patients: A Retrospective Cohort Study in IndonesiaHannah Soetjoadi0Dewi Friska1Bambang Budi Siswanto2Hary Sakti Muliawan3Faculty of Medicine, Universitas Indonesia, JakartaFaculty of Medicine, Universitas Indonesia, JakartaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, JakartaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, JakartaBackground: Plasma volume (PV) expansion hallmarks the syndrome of heart failure (HF) but is difficult to be quantified noninvasively. Estimated plasma volume status (ePVS) has marked prognostic utility in the failing left heart, however its use in right heart failure (RHF) remains unknown. This study aims to investigate the prognostic value of ePVS among isolated RHF patients. Methods: We retrospectively collected 208 patients admitted for RHF in our hospital from the electronic database from 2017 to 2019. ePVS was calculated using the Hakim formula. Patients were divided into low and high groups based on their PV value. Logistic regression was used to compare the odds of in-hospital mortality between these groups. Results: The overall in-hospital mortality was 12.5%, tripled from the low group to the high group (6.7% vs. 18.3%), within a median of 6 (3–19) days. High ePVS significantly predicted mortality in RHF, even after being adjusted for demographic, hemodynamic, chemistry, and medication variables (adjusted OR: 5.83, 95% CI: 1.62–20.95, 'p' < 0.01). Conclusion: ePVS is associated with in-hospital mortality among isolated RHF patients. Given not only the wide accessibility of hemogram but also the low cost and the rapid quantification of relative PV, this simple tool can potentially aid in optimizing RHF management, especially in rural area, although further evaluation is warranted.https://globalheartjournal.com/articles/1136plasma volumemortalityprognosisright ventricular failure
spellingShingle Hannah Soetjoadi
Dewi Friska
Bambang Budi Siswanto
Hary Sakti Muliawan
Impact of Estimated Plasma Volume Status on Mortality in Right Heart Failure Patients: A Retrospective Cohort Study in Indonesia
Global Heart
plasma volume
mortality
prognosis
right ventricular failure
title Impact of Estimated Plasma Volume Status on Mortality in Right Heart Failure Patients: A Retrospective Cohort Study in Indonesia
title_full Impact of Estimated Plasma Volume Status on Mortality in Right Heart Failure Patients: A Retrospective Cohort Study in Indonesia
title_fullStr Impact of Estimated Plasma Volume Status on Mortality in Right Heart Failure Patients: A Retrospective Cohort Study in Indonesia
title_full_unstemmed Impact of Estimated Plasma Volume Status on Mortality in Right Heart Failure Patients: A Retrospective Cohort Study in Indonesia
title_short Impact of Estimated Plasma Volume Status on Mortality in Right Heart Failure Patients: A Retrospective Cohort Study in Indonesia
title_sort impact of estimated plasma volume status on mortality in right heart failure patients a retrospective cohort study in indonesia
topic plasma volume
mortality
prognosis
right ventricular failure
url https://globalheartjournal.com/articles/1136
work_keys_str_mv AT hannahsoetjoadi impactofestimatedplasmavolumestatusonmortalityinrightheartfailurepatientsaretrospectivecohortstudyinindonesia
AT dewifriska impactofestimatedplasmavolumestatusonmortalityinrightheartfailurepatientsaretrospectivecohortstudyinindonesia
AT bambangbudisiswanto impactofestimatedplasmavolumestatusonmortalityinrightheartfailurepatientsaretrospectivecohortstudyinindonesia
AT harysaktimuliawan impactofestimatedplasmavolumestatusonmortalityinrightheartfailurepatientsaretrospectivecohortstudyinindonesia